ALAB

Astera Labs, Inc. Common Stock

81
Fundamentals89/ 100
Valuation63/ 100
Upside potential83/ 100
Risk potential29/ 100

ALAB has the edge over ASTS overall, supported by stronger fundamentals and stronger modeled upside.

ASTS

AST SpaceMobile, Inc.

49
Fundamentals66/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential46/ 100

ASTS trails on the overall score without a compensating advantage in the available component scores.

ALAB Fundamentals

MetricStatus
Strong
Strong
Strong
Strong

ALAB's revenue, profitability, cash flow and balance sheet are all currently strong.

ASTS Fundamentals

MetricStatus
Healthy
Weak
Weak
Unavailable

ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.

ALAB PE Valuation

CHEAPFAIREXPENSIVE73x147x220x293x
CHEAPFAIREXPENSIVE73x147x220x293x
LevelPEPriceVs current
Forward33x$228—
Cheap72x$182-20%
Current91x$228—
Fair108x$272+19%
Expensive172x$431+89%

Historical ranges are pointers, not guarantees.

ALAB's PE is in its fair range at 91x. If earnings grow as analysts expect, today's price would be 33x next year's earnings, in its cheap range.

ASTS PE Valuation

ASTS has no meaningful PE right now: it lost money over the past year.

ALAB Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
High

Analysts expect strong earnings and revenue growth for ALAB, with profitability improving.

ASTS Forward outlook

MetricOutlook
--
Losses growing
Strong growth
--
Limited
Low

Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.

ALAB Risk to reward

ScenarioChangePrice
Upside+141%$549.59
Downside-29%$161.16

Calculated from the latest close: $227.79 on Nov 12.

ALAB has a better modeled risk to reward balance than ASTS, with more potential upside and less potential downside.

ASTS Risk to reward

ScenarioChangePrice
Upside+86%$64.16
Downside-46%$18.77

Calculated from the latest close: $34.50 on Nov 12.

ASTS trails ALAB on modeled risk to reward, with less potential upside and more potential downside.

ALAB Earnings Per Share

Q4 2023: $-0.21Q1 2024: $-1.85Q2 2024: $-1.75Q3 2024: $-1.78Q4 2024: $-0.64Q1 2025: $1.31Q2 2025: $1.65Q3 2025: $2.20Q4 2025: $1.22Q1 2026: $1.48Q2 2026: $2.02Q3 2026: $2.51Forward: $6.88
Q4 2023: $-0.21Q1 2024: $-1.85Q2 2024: $-1.75Q3 2024: $-1.78Q4 2024: $-0.64Q1 2025: $1.31Q2 2025: $1.65Q3 2025: $2.20Q4 2025: $1.22Q1 2026: $1.48Q2 2026: $2.02Q3 2026: $2.51Forward: $6.88
QuarterTTM EPSYoY
Forward$6.88+174%
Q3 2026$2.51+14%
Q2 2026$2.02+22%
Q1 2026$1.48+13%
Q4 2025$1.22+$1.86
Q3 2025$2.20+$3.98
Q2 2025$1.65+$3.40
Q1 2025$1.31+$3.16
Q4 2024-$0.64-$0.43

ALAB has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.

ASTS Earnings Per Share

Q1 2024: $-0.98Q2 2024: $-1.25Q3 2024: $-2.12Q4 2024: $-1.95Q1 2025: $-1.99Q2 2025: $-1.89Q3 2025: $-1.24Q4 2025: $-1.34Q1 2026: $-1.80Q2 2026: $-2.16Q3 2026: $-2.15
Q1 2024: $-0.98Q2 2024: $-1.25Q3 2024: $-2.12Q4 2024: $-1.95Q1 2025: $-1.99Q2 2025: $-1.89Q3 2025: $-1.24Q4 2025: $-1.34Q1 2026: $-1.80Q2 2026: $-2.16Q3 2026: $-2.15
QuarterTTM EPSYoY
Q3 2026-$2.15-$0.91
Q2 2026-$2.16-$0.27
Q1 2026-$1.80+$0.19
Q4 2025-$1.34+$0.61
Q3 2025-$1.24+$0.88
Q2 2025-$1.89-$0.64
Q1 2025-$1.99-$1.01
Q4 2022-$0.58-$0.21

ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.

ALAB Quarterly Revenue

Q4 2023: $51MQ1 2024: $65MQ2 2024: $77MQ3 2024: $113MQ4 2024: $141MQ1 2025: $159MQ2 2025: $192MQ3 2025: $231MQ4 2025: $271MQ1 2026: $308MQ2 2026: $392MQ3 2026: $585M
Q4 2023: $51MQ1 2024: $65MQ2 2024: $77MQ3 2024: $113MQ4 2024: $141MQ1 2025: $159MQ2 2025: $192MQ3 2025: $231MQ4 2025: $271MQ1 2026: $308MQ2 2026: $392MQ3 2026: $585M
QuarterRevenueYoY
Q3 2026$584.9M+154%
Q2 2026$392.4M+104%
Q1 2026$308.4M+93%
Q4 2025$270.6M+92%
Q3 2025$230.6M+104%
Q2 2025$191.9M+150%
Q1 2025$159.4M+144%
Q4 2024$141.1M+179%

ALAB's revenue has grown year over year for 13 quarters in a row: $585M last quarter, up 154% from the same quarter a year ago.

ASTS Quarterly Revenue

Q4 2023: $0Q1 2024: $500,000Q2 2024: $900,000Q3 2024: $1MQ4 2024: $2MQ1 2025: $718,000Q2 2025: $1MQ3 2025: $15MQ4 2025: $54MQ1 2026: $15MQ2 2026: $32MQ3 2026: $42M
Q4 2023: $0Q1 2024: $500,000Q2 2024: $900,000Q3 2024: $1MQ4 2024: $2MQ1 2025: $718,000Q2 2025: $1MQ3 2025: $15MQ4 2025: $54MQ1 2026: $15MQ2 2026: $32MQ3 2026: $42M
QuarterRevenueYoY
Q3 2026$42.3M+187%
Q2 2026$31.5M+2627%
Q1 2026$14.7M+1952%
Q4 2025$54.3M+2731%
Q3 2025$14.7M+1240%
Q2 2025$1.2M+28%
Q1 2025$718K+44%
Q3 2022$4.2M+70%

ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.

ALAB Free Cash Flow

Q4 2023: $13MQ1 2024: $228,000Q2 2024: $31MQ3 2024: $47MQ4 2024: $24MQ1 2025: $6MQ2 2025: $133MQ3 2025: $66MQ4 2025: $77MQ1 2026: $67MQ2 2026: $67MQ3 2026: $134M
Q4 2023: $13MQ1 2024: $228,000Q2 2024: $31MQ3 2024: $47MQ4 2024: $24MQ1 2025: $6MQ2 2025: $133MQ3 2025: $66MQ4 2025: $77MQ1 2026: $67MQ2 2026: $67MQ3 2026: $134M
QuarterFree cash flowYoY
Q3 2026$133.9M+103%
Q2 2026$67.2M-50%
Q1 2026$67M+1023%
Q4 2025$76.6M+216%
Q3 2025$65.9M+41%
Q2 2025$133.3M+328%
Q1 2025$6M+2516%
Q4 2024$24.3M+81%

ALAB has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.

ASTS Free Cash Flow

Q4 2023: −$47MQ1 2024: −$88MQ2 2024: −$38MQ3 2024: −$64MQ4 2024: −$110MQ1 2025: −$149MQ2 2025: −$354MQ3 2025: −$303MQ4 2025: −$331MQ1 2026: −$310MQ2 2026: −$695MQ3 2026: −$464M
Q4 2023: −$47MQ1 2024: −$88MQ2 2024: −$38MQ3 2024: −$64MQ4 2024: −$110MQ1 2025: −$149MQ2 2025: −$354MQ3 2025: −$303MQ4 2025: −$331MQ1 2026: −$310MQ2 2026: −$695MQ3 2026: −$464M
QuarterFree cash flowYoY
Q3 2026-$464.2M-$161.4M
Q2 2026-$694.8M-$341.1M
Q1 2026-$309.7M-$160.7M
Q4 2025-$330.7M-$220.3M
Q3 2025-$302.9M-$239.1M
Q2 2025-$353.6M-$315.3M
Q1 2025-$149M-$61.3M
Q4 2024-$110.5M-$63.2M

ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.

ALAB Total Shares

Q4 2023: 153MQ1 2024: 53MQ2 2024: 155MQ3 2024: 157MQ4 2024: 131MQ1 2025: 178MQ2 2025: 178MQ3 2025: 181MQ4 2025: 180MQ1 2026: 181MQ2 2026: 183MQ3 2026: 184M
Q4 2023: 153MQ1 2024: 53MQ2 2024: 155MQ3 2024: 157MQ4 2024: 131MQ1 2025: 178MQ2 2025: 178MQ3 2025: 181MQ4 2025: 180MQ1 2026: 181MQ2 2026: 183MQ3 2026: 184M
PeriodChange %Net change
Quarterly+0.4%+737K shares
1 year+1.9%+3.4M shares
3 years+21%+31.6M shares

ALAB has the edge over ASTS on shareholder dilution, with a more favorable share count trend.

ASTS Total Shares

Q4 2023: 90MQ1 2024: 121MQ2 2024: 141MQ3 2024: 156MQ4 2024: 199MQ1 2025: 224MQ2 2025: 242MQ3 2025: 273MQ4 2025: 256MQ1 2026: 291MQ2 2026: 299MQ3 2026: 300M
Q4 2023: 90MQ1 2024: 121MQ2 2024: 141MQ3 2024: 156MQ4 2024: 199MQ1 2025: 224MQ2 2025: 242MQ3 2025: 273MQ4 2025: 256MQ1 2026: 291MQ2 2026: 299MQ3 2026: 300M
PeriodChange %Net change
Quarterly+0.4%+1.1M shares
1 year+10%+27.3M shares
3 years+235%+211M shares
5 years+480%+248M shares
Available history+944%+271M shares

ASTS has 300M diluted shares, up 10% from a year ago.

ALAB Net Leverage

Q2 2025: -3.5xQ3 2025: -1.3xQ4 2025: -0.9xQ1 2026: -0.6xQ2 2026: -0.4xQ3 2026: -0.5x
Q2 2025: -3.5xQ3 2025: -1.3xQ4 2025: -0.9xQ1 2026: -0.6xQ2 2026: -0.4xQ3 2026: -0.5x
QuarterNet LeverageStatus
Q3 2026-0.5xNet Cash
Q2 2026-0.4xNet Cash
Q1 2026-0.6xNet Cash
Q4 2025-0.9xNet Cash
Q3 2025-1.3xNet Cash
Q2 2025-3.5xNet Cash

ALAB has more cash than debt.

ASTS Net Leverage

ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

ALAB Weekly Momentum

MetricValueStatus
RSI43.1Neutral
Stochastic12.4Oversold

ALAB's weekly RSI is 43 (neutral) and its Stochastic is 12 (oversold).

ASTS Weekly Momentum

MetricValueStatus
RSI34.1Neutral
Stochastic11.9Oversold

ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).

ALAB PE vs Technology Sector

MetricALABSector medianRelative
PE91x28x226% above
PE %331716 pts above

ALAB is trading at 91x earnings, a 226% premium to the Technology sector's median of 28x.

ASTS PE vs Technology Sector

ASTS has no meaningful PE right now: it lost money over the past year.

ALAB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$284.720% below
20 week MA$306.926% below
50 week MA$241.45.6% below
100 week MA$182.725% above

ALAB has stronger trend alignment. ALAB is above 1 of 4 weekly averages versus ASTS above 1 of 5.

ASTS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$44.923% below
20 week MA$57.140% below
50 week MA$75.554% below
100 week MA$57.840% below
200 week MA$33.62.8% above

ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.

ALAB Yearly ROI

YearStart priceEnd priceROI
2024$70.0$141.5+102%
2025$141.5$167.3+18%
2026 YTD$167.3$227.8+36%

ALAB has the edge over ASTS on returns for 2026, with the stronger performance.

ASTS Yearly ROI

YearStart priceEnd priceROI
2020$9.87$13.4+36%
2021$13.4$8.71-35%
2022$8.71$3.97-54%
2023$3.97$6.03+52%
2024$6.03$22.9+280%
2025$22.9$72.0+214%
2026 YTD$72.0$34.5-52%

ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.

Give your agent the market.

Get API key